The Lifelong Cost of Surviving COVID: Scientists Uncover Long-Term Effects
A UC San Francisco study found that two-thirds of severe COVID-19 survivors in the US continued to suffer from various ...
Read moreTag: UCSF
Think Smoking Cannabis Won’t Damage Your Heart? Think Again
A study by UC San Francisco researchers indicates that the cardiac risks associated with smoking marijuana are on par with ...
Read more
COVID-19 Virus Can Stay in the Body More Than a Year After Infection
New research from UC San Francisco has found that COVID-19 can remain in the blood and tissue of some patients ...
Read more
Revolutionary AI Predicts Alzheimer’s up to Seven Years Before Symptoms Appear
UC San Francisco scientists have developed a method using machine learning to predict Alzheimer’s Disease up to seven years before ...
Read more
World’s First Tissue Bank Could Solve Mystery of Long COVID Misery
UC San Francisco is set to launch the first tissue bank for long COVID, following evidence that the virus persists ...
Read more
Unlocking Cancer’s Secret Weapon to Supercharge T-Cell Therapy
A groundbreaking study by UC San Francisco and Northwestern Medicine showcases a new T-cell therapy that significantly enhances the ability ...
Read more
Study Finds That Paxlovid Fails To Reduce Long COVID Risk
Researchers at UCSF found that Paxlovid does not reduce the risk of long COVID in vaccinated, non-hospitalized individuals and observed ...
Read more
New Research Shows Lifestyle Changes Can Prevent Dementia
A new study reveals that personalized health and lifestyle interventions can delay or prevent memory loss in older adults at ...
Read more
A good week for UCSF, bad one for San Jose cop
UCSF San Francisco campus opens new cutting-edge $535 million brain research facility to study and treat Alzheimer’s, autism, schizophrenia and depression, ...
Read moreA good week for UCSF prof, bad one for Papazian
David Julius UC San Francisco professor wins Nobel Prize, with biologist Ardem Patapoutian of Scripps Research in La Jolla, for ...
Read more
